Inability to screen high-risk populations: Existing screening methods often do not identify ovarian cancer in high-risk populations, such as women with a family history of ovarian cancer or known genetic mutations like BRCA1 and BRCA2. The gene discussed is BRCA2; the disease is ovarian carcinoma.